Home/Pipeline/BSEN760

BSEN760

Chronic Pain

Phase 1Active

Key Facts

Indication

Chronic Pain

Phase

Phase 1

Status

Active

Company

Bsense Bio Therapeutics

About Bsense Bio Therapeutics

Dual‑target small molecules for non‑opioid pain, tinnitus and itch relief.

View full company profile

Therapeutic Areas

Pain Tinnitus Pruritus

Other Chronic Pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Novel PNS System	Nervonik	First-in-Human Completed	Active
Pain Pipeline	Centrexion Therapeutics	Clinical Stage	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
Chronic Pain Program	Current Surgical	Research	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active